Etravirine Patent Expiration
Etravirine is used for treating HIV-1 infection in patients who are treatment-experienced and have evidence of viral replication and resistance to certain antiretroviral drugs. It was first introduced by Janssen Research And Development Llc
Etravirine Patents
Given below is the list of patents protecting Etravirine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Intelence |
US7037917 (Pediatric) | HIV replication inhibiting pyrimidines |
Jun 13, 2021
(Expired) | Janssen R And D |
| Intelence | US7037917 | HIV replication inhibiting pyrimidines |
Dec 13, 2020
(Expired) | Janssen R And D |
| Intelence |
US6878717 (Pediatric) | HIV replication inhibiting pyrimidines |
May 05, 2020
(Expired) | Janssen R And D |
| Intelence |
US8003789 (Pediatric) | HIV replication inhibiting pyrimidines |
May 01, 2020
(Expired) | Janssen R And D |
| Intelence | US6878717 | HIV replication inhibiting pyrimidines |
Nov 05, 2019
(Expired) | Janssen R And D |
| Intelence | US8003789 | HIV replication inhibiting pyrimidines |
Nov 01, 2019
(Expired) | Janssen R And D |
| Intelence |
US7887845 (Pediatric) | Antiviral compositions |
Sep 25, 2019
(Expired) | Janssen R And D |
| Intelence | US7887845 | Antiviral compositions |
Mar 25, 2019
(Expired) | Janssen R And D |
Etravirine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List